These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 28322465

  • 1. Opioid substitution therapy or hidden opioids are a minefield for nalmefene: an atypical case series of 11 patients in Lorraine.
    Yéléhé-Okouma M, Martini H, Lemarié J, Labroca P, Petitpain N, Gibaja V, Paille F, Gillet P.
    Fundam Clin Pharmacol; 2017 Oct; 31(5):574-579. PubMed ID: 28322465
    [Abstract] [Full Text] [Related]

  • 2. Severe opioid withdrawal syndrome after a single dose of nalmefene.
    Donnerstag N, Schneider T, Lüthi A, Taegtmeyer A, Raetz Bravo A, Mehlig A.
    Eur J Clin Pharmacol; 2015 Aug; 71(8):1025-6. PubMed ID: 26050241
    [No Abstract] [Full Text] [Related]

  • 3. Nalmefene Mistakenly Prescribed to Reduce Alcohol Consumption in Patients Under Buprenorphine Substitution Therapy Resulting in Acute Opioid Withdrawal: Management in an Emergency Setting.
    Pélissier F, Rougé Bugat ME, Nubukpo P, Franchitto N.
    J Clin Psychopharmacol; 2016 Feb; 36(1):100-3. PubMed ID: 26658085
    [No Abstract] [Full Text] [Related]

  • 4. [Nalmefene and Opioid Withdrawal Syndrome: Analysis of the Global Pharmacovigilance Database for Adverse Drug Reactions].
    Dahmke H, Kupferschmidt H, Kullak-Ublick GA, Weiler S.
    Praxis (Bern 1994); 2015 Oct 14; 104(21):1129-34. PubMed ID: 26463904
    [Abstract] [Full Text] [Related]

  • 5. Management of precipitated opiate withdrawal syndrome induced by nalmefene mistakenly prescribed in opiate-dependent patients: a review for clinicians.
    Franchitto N, Jullian B, Salles J, Pelissier F, Rolland B.
    Expert Opin Drug Metab Toxicol; 2017 Jun 14; 13(6):669-677. PubMed ID: 28343423
    [Abstract] [Full Text] [Related]

  • 6. Opioid Receptor Antagonists in the Treatment of Alcoholism.
    Serecigni JG.
    Adicciones; 2015 Sep 29; 27(3):214-30. PubMed ID: 26437315
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Nalmefene for the treatment of alcohol use disorders: recent data and clinical potential.
    Soyka M.
    Expert Opin Pharmacother; 2016 Sep 29; 17(4):619-26. PubMed ID: 26810044
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Naltrexone- or Nalmefene-Related Buprenorphine Withdrawal: Treat It With… More Buprenorphine.
    Lescut C, Gaboriau L, Carton L, Rolland B.
    J Clin Psychopharmacol; 2017 Oct 29; 37(5):631-633. PubMed ID: 28806388
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence.
    Gual A, He Y, Torup L, van den Brink W, Mann K, ESENSE 2 Study Group.
    Eur Neuropsychopharmacol; 2013 Nov 29; 23(11):1432-42. PubMed ID: 23562264
    [Abstract] [Full Text] [Related]

  • 19. Nalmefene for the management of alcohol dependence: review on its pharmacology, mechanism of action and meta-analysis on its clinical efficacy.
    Mann K, Torup L, Sørensen P, Gual A, Swift R, Walker B, van den Brink W.
    Eur Neuropsychopharmacol; 2016 Dec 29; 26(12):1941-1949. PubMed ID: 27842940
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.